Ask the Experts
Stuart McDougall is Principal Research Fellow of Bioanalytical Services at Quotient Sciences. Stuart has over 30 years of experience in the pharmaceutical industry within metabolism, pharmacokinetic, and bioanalysis roles.
Previous positions include being the global leader of Sanofi-Aventis' bioanalytical strategy team and a member of Covance's global bioanalytical leadership team.
Stuart is a pharmacology graduate from the University of Dundee, a harmonization team leader for the Global Bioanalytical Consortium (GBC), a representative for Quotient Sciences on the European Bioanalytical Forum (EBF), and an author and co-author of numerous scientific papers.
Delivering rapid bioanalytical data is critical to drug development. Through the use of robust bioanalytical techniques, biological samples can be processed and analyzed to identify and quantify compounds of interest, such as small molecules and their metabolites, as well as peptides, proteins, nucleic acids, and other analytes.
See insight from our bioanalysis team presented at the European Bioanalysis Forum (EBF):
"Novel Copper Protein Speciation Method for Calculating Serum Non-Ceruloplasmin Copper: A Comparative Analysis" describes a comparative analysis of a novel method for calculating serum non-ceruloplasmin-bound copper (NCC) levels in patients with Wilson disease (WD).
"Analysis of Ranitidine Reference Materials Using a Six N-Nitrosamine LC-MS/MS Assay," describes an assay built to determine six pharmaceutically relevant N-nitrosamines in both drug substances and drug products. The assay was applied to determine N-nitrosamines in three different ranitidine reference materials.